GlaxoSmithKline's (GSK) $54 Billion Consume Arm Said to Draw Buyout Firms - Bloomberg

October 12, 2021 6:20 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

GlaxoSmithKline's (NYSE: GSK) consumer unit is drawing interest from private equity firms as it prepares to split off the business. Advisers are informally fielding interest in the operations alongside preparations for a listing.

Advent, Blackstone (NYSE: BX), The Carlyle Group (NASDAQ: CG), CVS Capital Partners, KKR & Co. (NYSE: KKR) and Permira are among potential suitors for the business It could also attracted some of the worlds biggest pharma and consumer companies.

The unt could be valued at $54 billion or more.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot M&A, Mergers and Acquisitions, Private Equity, Rumors, Spinoffs

Related Entities

The Carlyle Group, Permira